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Wepresentapatientwhoexperiencedairwayobstructionduringanelectiveesophagogastroduodenoscopy(EGD)underanesthesia
secondary to previously undiagnosed tracheomalacia. Physiology of airway obstruction with forced breathing maneuvers is
discussed along with the potential advantages of dexmedetomidine-ketamine sedation for management of patients with achalasia
undergoing outpatient endoscopic procedures.
1.Introduction
Patientswithachalasiaroutinelypresenttotheoutpatienten-
doscopy suite for EGD with or without therapeutic BOTOX
injection under sedation. Achalasia may be rarely associated
with airway obstruction from megaesophagus. Sudden ob-
struction secondary to tracheomalacia with dynamic airway
collapse has not been reported previously. Diverse options
exist for the anesthetic management of such cases, and the
utility of dexmedetomidine for sedation in medically com-
plex patients is increasingly evident.
2.CaseReport
An 85-year-old gentleman (73kg, 180.3cm) with severe,
symptomatic achalasia felt to be a poor surgical risk and
therefore a poor candidate for surgical myotomy or pneu-
matic dilatation presented to the outpatient ambulatory
endoscopycenterforEGDwithesophagealBOTOXinjection
under anesthesia after previously undergoing an uncompli-
cated similar procedure some months before. Prior to the
procedure, he was kept nil per os (NPO) for 18 hours to pro-
mote esophageal drainage. Standard monitors (SpO2,E C G ,
and noninvasive BP) and nasal cannula oxygen (4L) with
capnometry were applied. Intravenous midazolam (1mg)
and glycopyrrolate (0.2mg) were administered, the patient
was placed in the left-lateral decubitus position, and an oral
bite block was inserted. A bolus of 6mL of ketofol (propofol
10mg/mL with ketamine 1mg/mL) wasgiven and the proce-
dure started. Spontaneous ventilation, as assessed by obser-
vation and capnometry, was maintained. The endoscope
passed smoothly into the proximal esophagus without a pa-
tient response, but upon esophageal insuﬄation a bolus of
solid food matter was propelled into the oropharynx accom-
panied by active patient coughing. Prompt and thorough
oropharyngeal suctioning was performed along with a jaw
thrust and chin lift. The patient continued to make respira-
tory eﬀorts,butnoairexchangewasdetectedbycapnometry,
and paradoxical chest wall movement was observed. Passage2 Case Reports in Anesthesiology
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Figure 1: Trachea during bronchoscopic examination demonstrat-
ing tracheomalacia.
of a lubricated nasal trumpet and placement of a Guedel
airway did not alleviate the obstruction, and signiﬁcant oxy-
gen desaturation occurred. The procedure was abandoned.
Face mask oxygen and gentle positive pressure via bag-mask
ventilation promptly restored gas exchange and oxygen satu-
ration to >95%, and the patient began to emerge from an-
esthesia. Brief ﬂexible ﬁberoptic examination of the glottic
opening via the right naris revealed no particulate matter or
other obstruction in the glottic inlet. Under light sedation
and topicalization of the oropharynx, a pulmonologist per-
formed a complete ﬂexible bronchoscopic exam that reveal-
ed extensive tracheomalacia from the vocal cords to the
carina, including portions of the right mainstem bronchus
(Figure 1). Dynamic tracheal collapse was evident during
spontaneous ventilation involving the anterolateral but not
posterior wall. The patient emerged from anesthesia and was
transported to the recovery room on nasal cannula oxygen.
He was awake and alert with stable vital signs and SpO2 94–
99%. Chest CT performed shortly after the aborted proce-
dure revealed mild inﬂammation and an enlarged sigmoid-
shaped esophagus consistent with long-standing achalasia.
Dynamic airway maneuvers to assess tracheal diameters were
not performed.
The patient was rescheduled for EGD and BOTOX in-
jection after 48 hours of NPO. He was brought to the pro-
cedure room at which time standard monitors and nasal
cannula oxygen with capnometry were applied. The patient
was placed in the left recumbent position and glycopy-
rrolate 0.2mg IV was administered followed by dexmedet-
omidine 1.5mcg/kg over ﬁfteen minutes then infusion at
0.7mcg/kg/h. Topical anesthesia of the right naris was ac-
complished with lidocaine. An intravenous bolus of 0.5mg/
kg ketamine was given followed by infusion at1mcg/kg/min.
A ﬂexible pediatric ﬁberoptic bronchoscope was passed via
the right naris to obtain a clear view of the vocal cords, and
smooth passage of the endoscope into the esophagus was
also visualized. The patient demonstrated minimal response
to either procedure, while spontaneous ventilation and
oxygenation were maintained. The residual liquid contents
of the dilated esophagus were briskly evacuated, and 100
units of BOTOX were injected into the gastroesophageal
junction in divided doses. There was no evidence of
proximal airway obstruction from the limited view via the
ﬁberscope. The patient coughed several times in response to
secretions reaching the arytenoid cartilages suggesting pres-
ervation of protective airway reﬂexes under the sedation reg-
imen. The procedure was completed smoothly, and the pa-
tientwasawakeandconversantwithintenminutesoftheces-
sation of infusions. During the procedure, there was no evi-
dence of dynamic airway collapse: continuous capnograph-
ic evidence of CO2 was present and the patient demonstrat-
ed no hemodynamic instability, respiratory depression, or
decrease in oxygen saturation. The patient was discharged to
outpatientfollowupwithaplanforrepeatEGDinduecourse
and evaluation for possible nighttime CPAP delivery.
3. Discussion
To our knowledge, this is the ﬁrst clinical report of dynamic
airway collapse secondary to undiagnosed tracheomalacia in
a patient with advanced achalasia.
Achalasia is an uncommon motility disorder of the
esophagusthatdevelopssecondarytodegenerationofinhibi-
tory neurons in the enteric plexi. The clinical result is aper-
istalsis of the lower esophageal body and incomplete relax-
ation of the lower esophageal sphincter due to unbalanced
activity of excitatory neurons. The resulting slow passage of
solid and liquid food presents clinically as dysphagia with
retained food matter and megaesophagus [1].
Treatment with BOTOX injection to relax the lower eso-
phageal sphincter has become the mainstay of achalasia
therapy in patients deemed to be unﬁt for surgical myotomy
or pneumatic dilation and is often also employed early in
the disease process as a diagnostic trial. Endoscopic BOTOX
injection is commonly performed under nurse-administered
midazolam/fentanyl sedation in the outpatient GI suite
though airway protection is often a concern, especially in pa-
tients with massively dilated esophagi as in the case under
discussion. For patients who fail traditional sedation, a va-
riety of approaches are employed ranging from propofol
sedation to endotracheal intubation with rapid sequence in-
duction. Indeed, prior to these encounters, our patient was
variably managed with nurse-administered sedation, endo-
tracheal intubation, and propofol-only deep sedation for
similar procedures. Although uncommon, airway obstruc-
tion secondary to massive esophageal dilation with resulting
posterior tracheal wall compression has been reported in
children and adults with achalasia [2, 3]. Management re-
quires immediate tracheal intubation, positive pressure ven-
tilation, and esophageal decompression.
Acquired adult tracheobronchomalacia has many etiolo-
gies but is commonly idiopathic or secondary to chronic in-
ﬂammation from recurrent infection and often presents in
later life [4]. Symptoms may not be present until late in the
disease process when degeneration of the tracheal cartilages
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tomatic asthma, and the presentation is further muddled by
concomitant achalasia. Airway collapse results in changes in
transtracheal pressure gradients that cannot be compensated
for by the weakened tracheal wall. Unmasking of tracheoma-
lacia under general anesthesia has been described previously
[5].
Without prior knowledge of tracheomalacia in this pa-
tient, propofol-ketamine was selected for the sedation. The
addition of ketamine may reduce the total dose of propofol
required while also providing analgesic properties that blunt
the response to endoscopy. When used as a sole agent, ket-
amine is believed to preserve airway reﬂexes, but the ability
of low-dose ketamine to potentiate the depressive eﬀects of
propofol on these reﬂexes has not been formally studied. In
our typical patient, a small loading dose of the ketofol mix-
ture (0.5–0.8mg/kg) is administered followed by expedient
passage of the endoscope into the esophagus with prompt
aspiration of any residual contents by the endoscopist.
In this patient, passive regurgitation triggered a robust
and protective cough reﬂex that persisted and was accom-
panied by airway obstruction not relieved by standard inter-
ventions. Reopening of the airway required positive pressure
mask ventilation, which was consistent with dynamic upper
or lower airway collapse.
We considered three primary mechanisms for the ob-
served phenomenon. These are (1) posterior tracheal col-
lapse from external esophageal compression; (2) upper air-
way with concomitant extrathoracic tracheal obstruction
secondarytotheM¨ uellermaneuver;(3)intrathoracictrache-
alcollapsedue to repeated Valsalva maneuver. Laryngospasm
from insuﬃcient depth of anesthesia was a consideration;
however, the ability to mask ventilate immediately with pos-
itive pressure and the observed tracheomalacia during bron-
choscopy make this possibility signiﬁcantly less compelling.
The ﬁrst mechanism has been reported on several occasions
in the literature [6]. However, the bronchoscopic ﬁnding
of diﬀuse tracheobronchomalacia of the anterolateral wall
decreases the likelihood of esophagus-mediated compres-
sion.
The M¨ ueller maneuver is used clinically in the diagno-
sis of obstructive sleep apnea in the awake patient, as de-
scribed in early literature by Sher and colleagues [7]. The
maneuver is characterized by inspiration from functional re-
sidual capacity (FRC) against a closed airway (i.e., closed
mouth and nares) that results in airway collapse at the hypo-
pharynx, base of tongue, or lateral pharyngeal wall as de-
tected by manometry or ﬁberoptic nasal endoscopy [8]. We
hypothesize that only extrathoracic areas of weakened tra-
chea or pharyngeal soft tissue would demonstrate collapse
with the Mueller maneuver. Moreover, relief of obstruction
was attempted with multiple interventions (nasal trumpet,
jaw thrust, and Guedel airway) that should have facilitated
the opening of the proximal airways.
A forced expiratory maneuver is a part of the CT airway
diagnostics for tracheomalacia [9]. In contrast, the Valsalva
maneuver is a forced expiration against a closed glottis. A
Valsalva maneuver signiﬁcantly increases intrathoracic pres-
sure against a closed glottis such that areas of intrathoracic
tracheomalacia will collapse. Cough, deﬁned as forced
expiration against a closed glottis after inspiration, would
result in a similar clinical picture. Suto and Tanabe employed
MRI to demonstrate that coughing decreased tracheal cross-
sectional area more than forced expiration in patients
with tracheomalacia but not in healthy control subjects [10].
The tracheomalacia in this patient was too extensive for
stenting. Evaluation was planned for nocturnal CPAP to pro-
tect against obstruction and hypoxemia during sleep. How-
ever,urgentBOTOXinjectionforsymptomaticreliefofacha-
lasia was indicated and the plan was to proceed after pro-
longed NPO status.
Concernsintheanestheticplanningincludedairwaypro-
tection from possible regurgitation of residual esophageal
contents and the anticipation of possible dynamic tracheal
collapse. There is no ideal approach. Some might consider
rapid sequence induction (RSI) with cricoid pressure and
intubation to be an optimal approach. The true risk of clin-
ically signiﬁcant aspiration in patients with achalasia is not
known. Sellick’s maneuver is not 100% eﬀective in prevent-
ing aspiration and may in some patients actually displace the
esophagus laterally or impair visualization of the glottic inlet
[11]. A disadvantage of succinylcholine in the ambulatory
surgery population is the possibility of profound myalgia.
Moreover, in this patient, emergence and extubation are not
straightforward. Incomplete evacuation of gastric contents
and air following the procedure may potentiate the risk of
regurgitation, particularly if deep extubation is attempted.
Tracheal collapse distal to the endotracheal tube may also
occur with cessation of positive pressure ventilation or with
profound straining (Valsalva) in response to the endotra-
chealtubeatemergence.Asedatedﬁberopticintubationwith
theairwaytopicalizedwithlocalanestheticcouldalsobecon-
sidered. This approach carries the disadvantage of a longer
preparation time for planned repeat procedures and the risk
of aspiration of gastric contents once the airway reﬂexes are
ablated by local anesthetic and sedation that will carry over
into the postextubation period.
Dexmedetomidine (DEX) is a selective, central α2-ago-
nist with pharmacologic properties that include moderate
sedation with anxiolysis, minimal respiratory depression,
and preservation of airway reﬂexes. Compared with propo-
fol, dexmedetomidine may better preserve upper airway tone
[12]. The clinical eﬀects of DEX are likely mediated through
a central action in the locus coeruleus. Eﬀective use of DEX
for sedation in a variety of complex procedures, including
ﬁberoptic intubation, has been demonstrated repeatedly in
the literature, and the US FDA has recently expanded indica-
tions for DEX to include procedural sedation [13]. Ketamine
is an NMDA receptor antagonist that provides amnesia and
hypnosis through central dissociative mechanisms involving
disruption of thalamic signaling pathways. Ketamine also
promotes maintenance of spontaneous ventilation and pres-
ervationofairwayreﬂexes.Thecombinationofketamineand
racemic medetomidine is employed extensively for large an-
imal surgery. A few recent literature reports describe the ef-
fective use of a ketamine-dexmedetomidine combination for
procedural sedation [14–16].
We found the dexmedetomidine-ketamine combination
to be highly eﬀective in this circumstance. The patient was4 Case Reports in Anesthesiology
nonresponsive to passage of either scope yet maintained nor-
mal airway tone with no respiratory depression. The proper-
ties of dexmedetomidine do not lend it to use as a sole agent
forinvasiveproceduresthatcausepain.Mildbradycardiaand
hypertension are associated with dexmedetomidine loading.
Large, rapid bolus doses of dexmedetomidine (>2mcg/kg)
may be associated with eﬀects on the ventilatory response to
hypercarbia, airway tone, and hemodynamics. The combi-
nation of dexmedetomidine with additional agents for hyp-
nosis, amnesia, or analgesia is optimal and may oﬀset the
limited side-eﬀect proﬁle of dexmedetomidine. Similarly,
dexmedetomidine may balance the sialorrhea and sympa-
thetic stimulation encountered with ketamine.
Fiberopticvisualizationoftheendoscopicprocedurepro-
vided real-time airway assessment and a conduit for imme-
diate airway rescue in the event of tracheal collapse. Vocal
cord closure and cough reﬂex in response to saliva-based
secretions in the glottic inlet were directly conﬁrmed,
thus demonstrating the maintenance of protective airway
reﬂexes with this anesthetic regimen. Importantly, transnasal
ﬁberoptic endoscopy demonstrated no dynamic upper air-
way collapse, during the procedure. However, in the event
of intrathoracic tracheal collapse the ﬂexible ﬁberoptic bron-
choscope was positioned ready to advance through the col-
lapsed segment after which oxygen could be delivered by jet
ventilation via the suction port.
In summary, the management of patients with achala-
sia for endoscopic procedures presents numerous clinical
challenges that are exacerbated by uncommon comorbidities
such as tracheomalacia. The utility of dexmedetomidine in
the management of this patient with a precarious airway
and further evidence of the unique properties of a dexme-
detomidine-ketamine combination in preservation of airway
reﬂexes are discussed. This case oﬀers an unconventional but
eﬃcaciousandclinicallysoundapproachtoendoscopyinthe
setting of achalasia.
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